1. Home
  2. TUSK vs SGMO Comparison

TUSK vs SGMO Comparison

Compare TUSK & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TUSK
  • SGMO
  • Stock Information
  • Founded
  • TUSK 2014
  • SGMO 1995
  • Country
  • TUSK United States
  • SGMO United States
  • Employees
  • TUSK N/A
  • SGMO N/A
  • Industry
  • TUSK Oilfield Services/Equipment
  • SGMO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • TUSK Energy
  • SGMO Health Care
  • Exchange
  • TUSK Nasdaq
  • SGMO Nasdaq
  • Market Cap
  • TUSK 109.4M
  • SGMO 122.8M
  • IPO Year
  • TUSK 2016
  • SGMO 2000
  • Fundamental
  • Price
  • TUSK $2.05
  • SGMO $0.56
  • Analyst Decision
  • TUSK
  • SGMO Strong Buy
  • Analyst Count
  • TUSK 0
  • SGMO 7
  • Target Price
  • TUSK N/A
  • SGMO $5.29
  • AVG Volume (30 Days)
  • TUSK 92.4K
  • SGMO 4.4M
  • Earning Date
  • TUSK 10-31-2025
  • SGMO 11-06-2025
  • Dividend Yield
  • TUSK N/A
  • SGMO N/A
  • EPS Growth
  • TUSK N/A
  • SGMO N/A
  • EPS
  • TUSK N/A
  • SGMO N/A
  • Revenue
  • TUSK $186,316,000.00
  • SGMO $81,706,000.00
  • Revenue This Year
  • TUSK N/A
  • SGMO $28.47
  • Revenue Next Year
  • TUSK $28.22
  • SGMO N/A
  • P/E Ratio
  • TUSK N/A
  • SGMO N/A
  • Revenue Growth
  • TUSK 84.11
  • SGMO 565.52
  • 52 Week Low
  • TUSK $1.68
  • SGMO $0.41
  • 52 Week High
  • TUSK $4.00
  • SGMO $3.18
  • Technical
  • Relative Strength Index (RSI)
  • TUSK 37.52
  • SGMO 38.83
  • Support Level
  • TUSK $2.01
  • SGMO $0.56
  • Resistance Level
  • TUSK $2.15
  • SGMO $0.62
  • Average True Range (ATR)
  • TUSK 0.09
  • SGMO 0.05
  • MACD
  • TUSK -0.01
  • SGMO -0.01
  • Stochastic Oscillator
  • TUSK 14.29
  • SGMO 5.02

About TUSK Mammoth Energy Services Inc.

Mammoth Energy Services Inc is an integrated energy services company engaged in providing products and services to enable the exploration and development of North American onshore unconventional oil and natural gas reserves as well as the construction and repair of the electric grid for private utilities, public investor-owned utilities, and co-operative utilities through infrastructure services businesses. The company had three reportable segments, which includes well completion services (Well Completion), infrastructure services (Infrastructure) and natural sand proppant services (Sand). Key revenue is generated from Infrastructure which include electric utility infrastructure services to government-funded utilities, private utilities, public investor-owned utilities, etc.

About SGMO Sangamo Therapeutics Inc.

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.

Share on Social Networks: